TALIS BIOMEDICAL CORP (TLIS) Stock Cash Flow
NASDAQ:TLIS - Nasdaq - US87424L2079 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -51.03M | -62.01M | -113.01M | -192.04M | -91.13M | |||
| Depreciation Amortization | 774.00K | 770.00K | 8.83M | 1.58M | 763.00K | |||
| Change In Working Capital | -3.76M | -3.42M | -7.69M | 8.82M | -951.00K | |||
| Other non cash items | 13.75M | 11.42M | 11.73M | 10.25M | 4.29M | |||
| OPERATING CASH FLOW | -40.26M | -53.24M | -100.14M | -171.38M | -87.02M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 23.00K | -486.00K | -1.61M | -2.87M | -8.20M | |||
| INVESTING CASH FLOW | 137.00K | -486.00K | -1.61M | -2.87M | -8.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 2.00K | 33.00K | 406.00K | 234.43M | 248.21M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -1.45M | |||
| FINANCING CASH FLOW | 2.00K | 33.00K | 406.00K | 234.43M | 246.75M | |||
| CHANGE IN CASH | -40.12M | -53.69M | -101.34M | 60.18M | 151.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -40.26M | -53.24M | -100.14M | -171.38M | -87.02M | |||
| Capital Expenditure | 23.00K | -486.00K | -1.61M | -2.87M | -8.20M | |||
| FREE CASH FLOW | -40.23M | -53.73M | -101.75M | -174.25M | -95.22M | |||
All data in USD